Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2015 | 07-2014 | 07-2013 | 07-2012 | 07-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 386 | 2,439 | 985 | 1,492 | 3,790 |
| Marketable Securities | 920 | N/A | 514 | 561 | 1,061 |
| Receivables | 29 | 7 | 11 | 57 | 131 |
| Other current assets | 0 | 125 | 0 | 0 | 0 |
| TOTAL | $1,346 | $2,572 | $1,511 | $2,117 | $4,985 |
| Non-Current Assets | |||||
| PPE Net | 1 | N/A | 8,051 | 8,000 | 6,730 |
| Investments And Advances | 6 | 28 | 29 | 66 | 30 |
| Other Non-Current Assets | 26 | 25 | 0 | 69 | 101 |
| TOTAL | $33 | $54 | $8,080 | $8,135 | $6,861 |
| Total Assets | $1,379 | $2,625 | $9,591 | $10,252 | $11,846 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 127 | 117 | 76 | 282 | 537 |
| Other current liabilities | N/A | 1,746 | N/A | N/A | 151 |
| TOTAL | $127 | $1,863 | $76 | $282 | $688 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $127 | $1,863 | $76 | $282 | $688 |
| Shareholders' Equity | |||||
| Common Shares | 3,195 | 12,140 | 12,921 | 12,667 | 12,733 |
| Retained earnings | -2,886 | -11,436 | -3,587 | -3,344 | -2,428 |
| Other shareholders' equity | 943 | 58 | 180 | 647 | 853 |
| TOTAL | $1,252 | $762 | $9,515 | $9,970 | $11,159 |
| Total Liabilities And Equity | $1,379 | $2,625 | $9,591 | $10,252 | $11,846 |